ADALIMUMAB (ADL) - ANVISA Registration 80134860240

Access comprehensive regulatory information for ADALIMUMAB (ADL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80134860240 and manufactured by PROGENIKA BIOPHARMA S.A.. The registration is held by GRIFOLS BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including BUHLMANN LABORATORIES AG, BODITECH MED INC., and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
3 Competitors
80134860240
Registration Details
ANVISA Registration Number: 80134860240
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

PROMONITOR-ADL
Risk Class II

Registration Details

80134860240

25351310815201652

02513899000171

Company Information

Spain
PT: ESPANHA

Dates and Status

Jul 03, 2017

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "ADALIMUMAB (ADL)"